Overview
Lifeness - holistic medical treatment programme for weight loss - is a TGC Capital Partners portfolio company operating in the HealthTech category, with primary footprint across Europe. The investment thesis combines minority growth capital with embedded engineering, GTM, and governance capacity drawn from the Gateway Group operating organisation under a written operating mandate.
Where Lifeness fits in TGC’s thesis
HealthTech companies operate in markets where the buyer, payer, and end-user are usually different parties and where the regulatory surface area widens with every new geography. The companies that scale build clinical evidence, payer relationships, and regulatory operating muscle in parallel - not sequentially.
The execution work that Lifeness navigates - clinical-evidence generation, payer/reimbursement strategy, multi-jurisdiction regulatory operations (MDR, HIPAA, GDPR-health), and enterprise procurement against long hospital and insurer cycles - is the work that operator-led growth equity is structured to support. TGC’s HealthTech engagement model pairs minority capital with the operating bench needed to clear those constraints, rather than treating them as the founding team’s problem alone.
Regional context
TGC covers Europe through its operating base in the Netherlands and partner coverage across the Nordics, Benelux, UK, DACH, and France. The platform is structured to operate across the multi-jurisdiction certification, language, and procurement complexity that European scaleups inherit by default. Lifeness’s footprint in Europe markets is supported by the operating coverage TGC maintains across the region, including engineering, GTM, and governance specialists who can deploy alongside the founding team without relocation friction.
TGC’s role
TGC’s engagement with Lifeness is structured under the firm’s standard operator-led growth equity model: minority capital paired with embedded operating capacity drawn from the Gateway Group bench - engineers, GTM operators, governance specialists - deployed under a written operating thesis with quarterly milestones. The engagement is designed to support the next two operating stages of the company, not a single transaction event.
What we typically deploy
- Embedded engineering teams of 2–30 specialists scaled against the operating thesis
- GTM operators owning pipeline cadence, partnership development, and enterprise procurement support
- Governance specialists hardening reporting, controls, and board-ready operating infrastructure
- Cross-border scaling support across the Nordics, Benelux, UK, DACH, North America, Middle East, and India under one platform
- Capital-strategy support for follow-on rounds, M&A, and exit-readiness work as the operating thesis matures
Specific deployment shape varies by stage, sector, and the bottlenecks identified during the investment thesis work. Detailed case-study narratives are published as portfolio companies confirm metrics for external release.
Related portfolio companies
Other portfolio companies operating across Europe markets: Alvarium, AnalyzeMyCar.
Related reading
- Vertical SaaS investment thesis - the thesis that frames TGC’s engagements in this sector.
- Markets we cover - market coverage and local operating context.
- The TGC platform - how operator-led growth equity is structured.
- Engagement models - how the engagement shape varies by stage and operating thesis.
- TGC vs Private Equity and Venture Capital - how operator-led growth equity differs from capital-only models.